You are here

psoriasis

Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis

Clinical Trials Arena

Tue, 11/19/24 - 11:00 am

clinical trials

BMS reports four-year data from psoriasis treatment extension trial

Clinical Trials Arena

Fri, 05/17/24 - 11:14 am

Bristol Myers Squibb

clinical trials

LEO Pharma reports positive data from Phase III plaque psoriasis trial

Clinical Trials Arena

Wed, 05/8/24 - 11:01 pm

clinical trials

Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS

Pharma Voice

Wed, 03/27/24 - 10:56 am

cliincal trials

Bristol Myers Squibb

clinical trial diversity

J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis

BioSpace

Mon, 03/11/24 - 12:00 pm

clinical trials

UCB launches DTC Bimzelx ad blitz at the Oscars

Medical Marketing and Media

Sun, 03/10/24 - 08:23 pm

DTC advertising

Eli Lilly Has More Than an Ozempic Competitor -- Much More

Motley Fool

Wed, 02/21/24 - 11:14 am

Alzheimer's disease

Johnson & Johnson reports data from Phase II plaque psoriasis trial

Clinical Trials Arena

Thu, 02/8/24 - 11:14 am

clinical trials

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake

Fierce Pharma

Tue, 11/28/23 - 11:29 pm

Even with phase 2 success, Ventyx halts TYK2 inhibitor, sending stock plummeting 70%

Fierce Biotech

Tue, 11/7/23 - 10:00 am

Ventyx Biosciences

clinical trials

TYK2 inhibitors

Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya

Clinical Trials Arena

Fri, 10/20/23 - 11:39 am

clinical trials

UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks

BioSpace

Thu, 10/19/23 - 10:15 am

Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs

Fierce Biotech

Tue, 10/17/23 - 09:57 pm

Evelo Biosciences

clinical trials

AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis

Fierce Pharma

Wed, 07/26/23 - 11:37 am

Boehringer Ingelheim

BMS’ Sotyktu cleared for NHS use in psoriasis

Pharmaphorum

Thu, 06/29/23 - 11:33 am

Bristol Myers Squibb

Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment

Clinical Trials Arena

Thu, 05/25/23 - 12:48 pm

real world data

Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease

Fierce Biotech

Thu, 04/6/23 - 10:01 am

prostate cancer

multiple sclerosis

Acquired patents aid J&J defense of top-selling drug from biosimilar challenge

BioPharma Dive

Wed, 03/29/23 - 03:56 pm

Biohaven strikes a deal to take TYK2 drugs in a new direction

BioPharma Dive

Thu, 03/23/23 - 09:05 pm

Hangzhou Highlightll

AbbVie’s Skyrizi hits the spot in refractory psoriasis

Pharmaphorum

Mon, 03/20/23 - 11:21 am

Pages